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Introduction:  Fluid  resuscitation  therapy  is  the  initial  step  of  treatment  for  hemorrhagic  shock.  In the
present  study  we  aimed  to  investigate  the  acute  effects  of  acetate-balanced  colloid  and  crystalloid
resuscitation  on  renal  oxygenation  in a rat  model  of hemorrhagic  shock.  We  hypothesized  that  acetate-
balanced  solutions  would  be superior  in  correcting  impaired  renal  perfusion  and  oxygenation  after  severe
hemorrhage  compared  to unbalanced  solutions.
Methods:  In  anesthetized,  mechanically  ventilated  rats,  hemorrhagic  shock  was  induced  by withdrawing
blood  from  the  femoral  artery  until  mean  arterial  pressure  (MAP)  was  reduced  to  30  mmHg.  One  hour
later, animals  were  resuscitated  with  either  hydroxyethyl  starch  (HES,  130/0.42  kDa)  dissolved  in saline
(HES-NaCl;  n  = 6) or a acetate-balanced  Ringer’s  solution  (HES-RA;  n  = 6),  as  well  as with  acetated  Ringer’s
solution  (RA;  n  =  6)  or 0.9%  NaCl  alone  (NaCl;  n  =  6) until  a  target  MAP  of  80  mmHg  was reached.  Oxy-
gen  tension  in the  renal  cortex  (CPO2),  outer  medulla  (MPO2),  and  renal  vein  were  measured  using
phosphorimetry.
Results:  Hemorrhagic  shock  (MAP  = 30 mmHg)  signiﬁcantly  decreased  renal  oxygenation  and  oxygen  con-
sumption.  Restoring  the  MAP  to  80  mmHg  required  24.8  ±  1.7  ml  of NaCl,  21.7  ±  1.4 ml of  RA,  5.9  ±  0.5  ml
of  HES-NaCl  (p <  0.05  vs.  NaCl  and  RA),  and  6.0  ±  0.4  ml  of  HES-RA  (p  < 0.05  vs. NaCl  and  RA). NaCl,  RA,  and
HES-NaCl  resuscitation  led  to  hyperchloremic  acidosis,  while  HES-RA  resuscitation  did  not.  Only  HES-
RA  resuscitation  could  restore  renal  blood  ﬂow  back  to  ∼85%  of  baseline  level  (from  1.9 ±  0.1  ml/min
during  shock  to 5.1  ml  ±  0.2  ml/min  60  min  after  HES-RA  resuscitation)  which  was  associated  with an
improved  renal  oxygenation  (CPO2 increased  from  24  ± 2  mmHg  during  shock  to  50 ±  2  mmHg  60  min
after  HES-RA  resuscitation)  albeit  not  to  baseline  level.  At  the  end  of  the protocol,  creatinine  clearance
was  decreased  in  all  groups  with  no differences  between  the  different  resuscitation  groups.
Conclusion:  While  resuscitation  with  the  NaCl  and  RA  (crystalloid  solutions)  and  the  HES-NaCl  (unbal-
anced  colloid  solution)  led to hyperchloremic  acidosis,  resuscitation  with  the  HES-RA  (acetate-balanced
colloid  solution)  did  not.  The  HES-RA  was  furthermore  the  only  ﬂuid  restoring  renal  blood  ﬂow  back  to
∼85% of  baseline  level  and  most  prominently  improved  renal  microvascular  oxygenation.. IntroductionHemorrhagic shock is the major cause of mortality after major
rauma and aggressive ﬂuid resuscitation is often the initial step
 A Spanish translated version of the summary of this article appears as Appendix
n  the ﬁnal online version at doi:10.1016/j.resuscitation.2012.02.011.
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to restore the circulating intravascular volume to prevent organ
hypoperfusion, organ failure, and eventually death.1,2 Acute renal
failure (ARF) is a serious complication contributing to the high
mortality in these patients.35 The use of conventional crystal-
loid solutions (e.g., isotonic saline) as initial resuscitation ﬂuids
is still implemented in emergency departments even though it
is known that crystalloid solutions have poor plasma expander
capacities and just 20% of the given volume remains contained
Open access under the Elsevier OA license.in the intravascular space.3 Hence, to restore perfusion, large
volumes of crystalloid solutions are required. Additionally, hyper-
chloremic acidosis is a known risk in patients treated with isotonic
saline. Hyperchloremia is suggested to cause afferent renal artery
tation
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asoconstriction in animal models, possibly leading to kidney
ysfunction.29,38,39 Hydroxyethyl starch (HES) solutions have been
sed clinically as a colloid solution, and have been shown to have
uperior plasma expanding capacities compared to traditional crys-
alloid solutions.4 However, these HES solutions, in turn, have been
uggested to have adverse effects on systemic coagulation proper-
ies and are potentially harmful for the kidney.5 Consequently, new
ES solutions (mean molecular weight: 130 kDa, degree of sub-
titution: 0.4; HES 130/0.4) have been developed and have been
hown to improve microvascular perfusion and reduce macro-
olecular leakage.6–9
Although effective in restoring systemic hemodynamic param-
ters, aggressive (i.e., large volume) ﬂuid resuscitation introduces
on-physiologic levels of plasma ions which depress microvas-
ular function and organ perfusion.10 The kidney is especially
usceptible for this type of injury due to its complex microvascu-
ar structure and high oxygen dependency.11 Over the past few
ears, research has therefore been focused on balancing ﬂuids
o optimally match physiological conditions and thereby pre-
ent microvascular dysfunction and organ hypoperfusion.12–14
alanced ﬂuids are suggested to have a more physiological elec-
rolyte composition than conventional saline-based ﬂuids.
In the present study we aimed to investigate the acute effects
f acetate-balanced colloid and crystalloid resuscitation on renal
xygenation in a rat model of hemorrhagic shock. To this end, we
xamined the effects of resuscitation with different ﬂuids: (1) 0.9%
aCl; (2) acetated Ringer’s solution; (3) 6% HES with a molecular
eight of 130 kDa and molar substitution of 0.4 (HES 130/0.4) in
.9% NaCl solution (HES-NaCl); and (4) 6% HES with a molecular
eight of 130 kDa and molar substitution of 0.42 (HES 130/0.42)
n acetate-balanced Ringer’s solution (HES-RA). We  hypothesized
hat acetated solutions would have superior resuscitation capac-
ties compared to the other solutions with respect to improving
enal oxygenation after severe hemorrhage.
. Materials and methods
.1. Animals
All experiments in this study were approved by the institutional
nimal Experimentation Committee of the Academic Medical Cen-
er of the University of Amsterdam. Care and handling of the
nimals were in accordance with the guidelines for Institutional
nd Animal Care and Use Committees. Experiments were per-
ormed on 30 Sprague-Dawley rats (Harlan, the Netherlands) with
ean ± SD body weight of 350 ± 20 g.
.2. Surgical preparation
The rats were anesthetized with an intraperitoneal injection of
 mixture of 100 mg/kg ketamine (Nimatek®; Eurovet, Bladel, the
etherlands), 0.5 mg/kg medetomidine (Domitor; Pﬁzer, New York,
Y), and 0.05 mg/kg atropine-sulfate (Centrafarm, Etten-Leur, the
etherlands). After tracheotomy, the animals were mechanically
entilated with an FiO2 of 0.4. Body temperature was maintained
t 37 ± 0.5 ◦C during the entire experiment by external warm-
ng. The ventilator settings were adjusted to maintain end-tidal
CO2 between 30 and 35 mmHg  and arterial PCO2 between 35 and
0 mmHg.
Vessels were cannulated with polyethylene catheters (outer
iameter = 0.9 mm;  Braun, Melsungen, Germany) for drug and ﬂuid
dministration and hemodynamic monitoring. A catheter in the
ight carotid artery was connected to a pressure transducer to
onitor mean arterial blood pressure (MAP) and heart rate. The
ight jugular vein was cannulated for continuous infusion of Ringer 83 (2012) 1166– 1172 1167
Lactate (Baxter, Utrecht, the Netherlands) at a rate of 15 ml/kg/h.
The right femoral artery was  cannulated for blood shedding and
the right femoral vein for ﬂuid resuscitation. The left kidney was
exposed, decapsulated, and immobilized in a Lucite kidney cup (K.
Effenberger, Pfafﬁngen, Germany) via a 4 cm incision in the left
ﬂank. Renal vessels were carefully separated under preservation
of nerves and adrenal gland. A perivascular ultrasonic transient
time ﬂow probe was  placed around the left renal artery (type 0.7
RB; Transonic Systems Inc., Ithaca, NY, USA) and connected to a
ﬂow meter (T206; Transonic Systems Inc.) to continuously measure
renal blood ﬂow (RBF). An estimation of the renal vascular resis-
tance (RVR) was made as RVR [dynes s cm−5] = (MAP/RBF) × 100.
The left ureter was isolated, ligated and cannulated with a polyethy-
lene catheter for urine collection. The surgical ﬁeld was  covered
with a humidiﬁed gauze compress throughout the entire experi-
ment to prevent drying of the exposed tissue.
After the surgical protocol (approximately 60 min) one optical
ﬁber was placed 1 mm above the decapsulated kidney and another
optical ﬁber 1 mm above the renal vein to measure oxygenation
using a phosphorescence lifetime technique. A small piece of alu-
minum foil was placed on the dorsal site of the renal vein to prevent
contribution of underlying tissue to the phosphorescence signal in
the venous PO2 measurement. Oxyphor G2 (a two-layer glutamate
dendrimer of tetra-(4-carboxy-phenyl) benzoporphyrin; Oxygen
Enterprises Ltd., Philadelphia, PA, USA) was subsequently infused
(6 mg/kg IV over 5 min) followed by a 30 min stabilization period.
A short description of the phosphorescence quenching method is
given below and a more detailed description of the technology has
been previously described.15
2.3. Experimental protocol
After stabilization, the animals in experimental groups were
bled by the left femoral artery catheter at a rate of 1 ml/min using a
syringe pump (Harvard 33 syringe pump; Harvard Apparatus, South
Natick, MA)  until a MAP  of 30 mmHg was reached which was  main-
tained for 1 h by re-infusing or withdrawing blood. Coagulation of
the shed blood was prevented by adding 200 UI of heparin in the
syringe.
At the end of the hemorrhage phase, the animals were ran-
domized into 5 groups for resuscitation until a target MAP  of
80 mmHg  was  reached with: (1) 0.9% NaCl (NaCl; Na+ 154 mmol l−1,
Cl− 154 mmol  l−1; pH 5.5; n = 6); (2) Ringer’s Acetate (RA; Na+
130 mmol  l−1, Cl− 112 mmol  l−1, K+ 5.4 mmol l−1, Ca+2 0.9 mmol l−1,
Mg+2 1.0 mmol  l−1, acetate− 27 mmol l−1; pH = 5.0–7.0; n = 6); (3)
6% HES with a molecular weight of 130 kDa and molar substitution
of 0.4 (HES 130/0.4) in 0.9% NaCl solution (HES-NaCl; Voluven®,
Fresenius Kabi, Bad Homburg, Germany; n = 6); or (4) 6% HES with
a molecular weight of 130 kDa and molar substitution of 0.42 (HES
130/0.42) in acetate-balanced Ringer’s solution (HES-RA; Plasma
Volume®, Baxter, Germany; n = 6). In addition, sham operated con-
trol experiments were performed (n = 6).
The experiments were terminated by infusion of 1 ml  of 3 M
potassium chloride (KCl).
2.4. Blood gas parameters
Arterial blood samples (0.5 ml)  were taken from the femoral
artery at time points: (1) baseline (BL, t = 0 min); (2) after hemor-
rhagic shock (HS, t = 60 min); (3) 15 min  after starting resuscitation
(R15, t = 75 min), and (4) at the end of the protocol (R60, t = 120 min).
The blood samples were replaced by the same volume of test
solution. The samples were used to determine blood gas parameters
(ABL505 blood gas analyzer; Radiometer, Copenhagen, Denmark),
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Table 1
Amount of resuscitation ﬂuid required to increase the mean arterial pressure from
30  to 80 mmHg  and the plasma sodium (Na+) and chloride (Cl−) concentrations and
plasma pH at baseline (BL) and after 60 min  of resuscitation (R60).
BL R60
Amount of ﬂuid required [ml]
Time control
HS control
0.9% NaCl 24.8 ± 1.7
Ringer’s Acetate 21.7 ± 1.4
HES-NaCl 5.9 ± 0.5N,R
HES-RA 6.0 ± 0.4N,R
Cl− [mmol  l−1]
Time control 104 ± 1 105 ± 2
HS  control 110.4 ± 1.1 119.5 ± 3.2
0.9% NaCl 87.2 ± 5.4 119.6 ± 6.1T
Ringer’s Acetate 105.6 ± 3.7 110.2 ± 1.7T
HES-NaCl 97.6 ± 1.2 112.4 ± 3.5T
HES-RA 102.4 ± 4.1 106 ± 3.5
Na+ [mmol  l−1]
Time control 142 ± 2 143 ± 2
HS  control 148.4 ± 2 149 ± 3.1
0.9% NaCl 141.8 ± 1.0 143.2 ± 0.8
Ringer’s Acetate 142.3 ± 1.2 144.2 ± 0.5
HES-NaCl 143.2 ± 1.0 143.8 ± 0.6
HES-RA 142.5 ±  0.9 143.8 ± 0.5
pH
Time control 7.31 ± 0.10 7.30 ± 0.10
HS  control 7.35 ± 0.01 7.11 ± 0.02
0.9% NaCl 7.27 ± 0.01 7.10 ± 0.03T
Ringer’s Acetate 7.31 ± 0.01 7.15 ± 0.01T
HES-NaCl 7.29 ± 0.03 7.20 ± 0.02T
HES-RA 7.31 ± 0.01 7.26 ± 0.02
T168 E. Almac et al. / Resusci
emoglobin concentration, and hemoglobin oxygen saturation
OSM 3, Radiometer).
.5. Renal microvascular and venous oxygenation
Microvascular oxygen tension in the renal cortex (CPO2),
uter medulla (MPO2), and renal venous oxygen tension (PrvO2)
ere measured by oxygen-dependent quenching of phospho-
escence lifetimes of the systemically infused albumin-targeted
and therefore circulation-conﬁned) phosphorescent dye Oxyphor
2.15–18 Oxyphor G2 (a two-layer glutamate dendrimer of tetra-
4-carboxy-phenyl) benzoporphyrin) has two excitation peaks
excitation1 = 440 nm,  excitation2 = 632 nm)  and one emission peak
emission = 800 nm).18 These optical properties allow (near) simul-
aneous lifetime measurements in microcirculation of the kidney
ortex and the outer medulla due to different optical penetra-
ion depths of the excitation light.15 For the measurement of
enal venous PO2 (PrvO2), a mono-wavelength phosphorimeter
as used.19 Oxygen measurements based on phosphorescence life-
ime techniques rely on the principle that phosphorescence can be
uenched by energy transfer to oxygen resulting in shortening of
he phosphorescence lifetime. A linear relationship between recip-
ocal phosphorescence lifetime and oxygen tension (given by the
tern–Volmer relation) allows quantitative measurement of PO2.
etails of the technique have previously been published.15
.6. Renal oxygen delivery and consumption
Arterial oxygen content (AOC) was calculated by
1.31 ×hemoglobin × SaO2) + (0.003 × PaO2), where SaO2 is arte-
ial oxygen saturation and PaO2 is arterial partial pressure of
xygen. Renal venous oxygen (RVOC) content was calculated
s (1.31 × hemoglobin × SrvO2) + (0.003 × PrvO2), where SrvO2 is
enous oxygen saturation and PrvO2 is renal vein partial pres-
ure of oxygen. Renal oxygen delivery was calculated as DO2
ml/min) = RBF × AOC. Renal oxygen consumption is calculated
s VO2ren (ml/min/g) = RBF × (AOC − RVOC). The renal oxygen
xtraction ratio was calculated as O2ERren (%) = VO2ren/DO2 × 100.
.7. Assessment of kidney function
Creatinine clearance (Clearcrea, [ml/min]) was  assessed as an
ndex of the glomerular ﬁltration rate. Calculation of the clearance
as done using the standard formula: Clearcrea = (Ucrea × V)/Pcrea,
here Ucrea is the concentration of creatinine in urine, V is the urine
olume per unit time and Pcrea is the concentration of creatinine in
lasma.
Furthermore, all urine samples were analyzed for sodium (Na+)
oncentration. The renal energy efﬁciency for sodium transport
VO2ren/TNa+ ) was assessed using the ratio of the total amount
f VO2ren over the total amount of sodium reabsorbed (TNa+ ,
mmol/min]).
.8. Statistical analysis
Values are reported as the mean ± SEM. The decay curves of
hosphorescence intensity were analyzed using software pro-
ramed in Labview 6.1 (National Instruments, Austin, TX, USA).
tatistical analysis was performed using GraphPad Prism version
.0 for Windows (GraphPad Software, San Diego, CA, USA). Two-
ay ANOVA with a Bonferroni post hoc test was used and a p-value
f <0.05 was considered statistically signiﬁcant.p<0.05 vs. time control.
N p < 0.05 vs. 0.9% NaCl.
R p < 0.05 vs. Ringer’s Acetate.
3. Results
3.1. Fluid and electrolyte balance
The amount of ﬂuids given during resuscitation and the plasma
chloride and sodium levels and plasma pH are presented in Table 1.
Restoring the MAP  from 30 mmHg  (shock) to 80 mmHg  required
24.8 ± 1.7 ml  of NaCl, 21.7 ± 1.4 ml  of RA, 5.9 ± 0.5 ml  of HES-NaCl
(p < 0.05 vs. NaCl and RA), and 6.0 ± 0.4 ml  of HES-RA (p < 0.05 vs.
NaCl and RA). Plasma chloride levels were signiﬁcantly increased
(p < 0.05 vs. time control) after NaCl (119.6 ± 6.1 mmol l−1), RA
(110.2 ± 1.7 mmol  l−1), and HES-NaCl (112.4 ± 3.5 mmol l−1) resus-
citation, but not after HES-RA (106.0 ± 3.5 mmol l−1) resuscitation.
Similarly, plasma pH was  signiﬁcantly decreased (p < 0.05 vs.
time control) after NaCl (7.10 ± 0.03), RA (7.15 ± 0.01), and HES-
NaCl (7.20 ± 0.02) resuscitation, but not after HES-RA (7.26 ± 0.02)
resuscitation. Hence, NaCl, RA, and HES-NaCl resuscitation led to
hyperchloremic acidosis, while HES-RA resuscitation did not.
3.2. Systemic and renal hemodynamics
Systemic and renal hemodynamic variables are presented in
Table 2. The baseline values measured in each group were found
to be similar (p > 0.05). In all groups, MAP, RBF decreased during
hemorrhage without signiﬁcant differences between groups.
During resuscitation, MAP  was  consistently increased in all
groups, though the target MAP  of 80 mmHg  was  not successfully
maintained after 60 min  of resuscitation. In crystalloid treated
groups, NaCl and RA, MAP  was  lower at the end of the protocol
(44 ± 4 and 48 ± 3 mmHg, respectively) compared to in the colloid
treated groups, HES-NaCl and HES RA (58 ± 5 and 52 ± 3 mmHg,
respectively).
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Table 2
Mean arterial pressure (MAP), renal blood ﬂow (RBF), and renal vascular resistance
(RVR) at baseline (BL), during hemorrhagic shock (HS), and after 15 and 60 min  of
resuscitation (R15 and R60, respectively).
BL HS R15 R60
MAP  [mmHg]
Time control 102 ± 1 104 ± 2 99 ± 3 105 ± 4
HS  control 95 ± 9 30 ± 2 30 ± 3 30 ± 2
0.9% NaCl 102 ± 2 31 ± 1 73 ± 8 44 ± 4
Ringer’s Acetate 101 ± 2 33 ± 1 57 ± 2H 48 ± 3
HES-NaCl 102 ± 3 31 ± 1 67 ± 6 58 ± 5
HES-RA 101 ± 3 32 ± 2 62 ± 3 52 ± 3
RBF [ml/min]
Time control 5.6 ± 0.4 5.6 ± 1.1 5.8 ± 0.6 5.5 ± 1.0
HS  control 5.4 ± 0.2 1.2 ± 0.2 1.1 ± 0.3 0.9 ± 0.2
0.9% NaCl 5.6 ± 0.3 1.4 ± 0.1 2.9 ± 0.6H 2.4 ± 0.5
Ringer’s Acetate 5.6 ± 0.4 1.4 ± 0.2 3.8 ± 0.5H 3.6 ± 0.4H
HES-NaCl 5.5 ± 0.2 1.7 ± 0.3 3.1 ± 0.3H 3.4 ± 0.4H
HES-RA 5.9 ± 0.2 1.9 ± 0.1 4.9 ± 0.4H 5.1 ± 0.2H,N
RVR [dyn s s−5]
Time control 16.4 ± 1.1 15.1 ± 1.5 17.2 ± 1.2 16.9 ± 1.5
HS  control 17.5 ± 1.8 24.5 ± 5.2 27.6 ± 5.4 37.7 ± 5.6
0.9% NaCl 18.6 ± 1.5 22.3 ± 1.8 29.3 ± 4.6 21.4 ± 3.5
Ringer’s Acetate 18.5 ± 1.5 20.8 ± 1.2 15.8 ± 2.5 14.2 ± 2.0
HES-NaCl 18.6 ± 1.3 19.9 ± 3.0 21.4 ± 3.5 18.7 ± 2.7
HES-RA 17.1 ± 1.0 17.6 ± 0.9 13.1 ± 1.0 10.2 ± 0.5H,N
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tH p < 0.05 vs. HS control.
N p < 0.05 vs. 0.9% NaCl.
Resuscitation improved RBF in all groups starting in the early
hase of resuscitation (p < 0.05). Improvement of RBF after 60 min
f resuscitation was most pronounced in the HES-RA group
5.1 ± 0.2 ml/min; 85% of baseline value) and least in 0.9% NaCl
roup (2.4 ± 0.5 ml/min; 42% of baseline value).
.3. Renal oxygenation
Renal DO2, VO2, CPO2, and MPO2 are presented in Table 3.
ll these parameters decreased during hemorrhage without sig-
iﬁcant differences between groups. At the end of resuscitation,
O2 was improved compared to hemorrhagic shock. This increase
as signiﬁcant in the RA group (0.41 ± 0.07 ml  O2/min) and HES-
A group (0.39 ± 0.06 ml  O2/min) compared to HS control (p < 0.05).
O2, however, could not be increased by ﬂuid resuscitation (p > 0.05
s. HS control).
Resuscitation improved CPO2 and MPO2 albeit not to base-
ine level. At R60, CPO2 was higher in the HES-RA group compared
o other groups and signiﬁcantly different comparing to the NaCl
roup (p < 0.05).
.4. Renal function
Creatinine clearance and VO2/TNa+ are presented in Fig. 1. There
ere no differences at baseline in creatinine clearance (not shown).
uring hemorrhagic shock urine production decreased dramati-
ally. In the HS control group, all animals suffered from anuria at
he end of the protocol. All groups had a lower creatinine clear-
nce at the end of resuscitation (p < 0.05 vs. time control). The NaCl
esuscitated group had the lowest creatinine clearance rate at R60.
he VO2/TNa+ was found to be unaffected by ﬂuid resuscitation.
. Discussion and conclusionsIn the present study, we examined the acute effects of acetate-
alanced colloid and crystalloid resuscitation on renal oxygenation
n a rat model of hemorrhagic shock. We  tested the hypothesis
hat acetate-balanced solutions would be superior in correcting 83 (2012) 1166– 1172 1169
impaired renal perfusion and oxygenation after severe hemorrhage
compared to unbalanced solutions. Our main ﬁndings were that: (1)
hemorrhagic shock was associated with acute decreases in blood
pressure, renal perfusion and oxygenation, and urine production;
(2) volume replacement therapy with balanced and unbalanced
crystalloid and colloid solutions partially corrected these parame-
ters; and (3) the acetate-balanced colloid solution HES-RA was  the
only resuscitation ﬂuid that could restore renal blood ﬂow back to
∼85% of baseline level which was  associated with the most promi-
nently improved renal oxygenation.
Hemorrhagic shock is one of the major causes of acute renal
failure due to decreased blood pressure and consequent hypoper-
fusion of the kidney. The presence of acute renal failure signiﬁcantly
increases morbidity and mortality.40 The ﬁrst step in the correction
of hemorrhage-induced hypotension is aggressive volume replace-
ment therapy12 which aims to increase the circulating intravascular
volume, blood pressure, and organ perfusion.9,34 However, in
contrast to blood, resuscitation ﬂuids have poor oxygen trans-
porting capacity and rheological properties. In addition, the ﬂuids
used for volume replacement therapy have been suggested to
increase inﬂammation and disturb homeostasis and the acid–base
balance.41–44 Over time, a variety of colloid and crystalloid solu-
tions has been used, including isotonic saline and saline-based
colloid solutions. Although saline-based solutions have been asso-
ciated with disturbed acid–base balance due to non-physiological
electrolyte composition and pH, these yet remain the most pop-
ular solutions for volume replacement therapy in peri-operative
care.22–25,29,38,39 With respect to the kidney, saline-based solutions
are known to be more frequently associated with hyperchloremic
acidosis, due to their high levels of chloride, resulting in renal vas-
cular constriction and decreased renal perfusion.26a,27,45 This we
have conﬁrmed in the present study.
Balanced solutions, in contrast, provide an alternative with opti-
mized physiological composition in terms of sodium, potassium,
calcium, magnesium, and chloride levels, and their relative con-
tributions regarding osmolality. Buffers such as acetate, gluconate,
pyruvate, and lactate can be used in resuscitation ﬂuids and are
converted to bicarbonate in liver and raise the pH of the solution
to normal blood pH (7.4). These solutions achieve a physiological
acid–base balance with either bicarbonate or metabolizable anions
and reduce of the risk of iatrogenic disruptions. In animal models of
sepsis it has also been demonstrated that balanced solutions lead to
less metabolic acidosis, reduced inﬂammatory cytokine levels, and
longer survival compared to resuscitation with normal saline.26b,32
Infusion of solutions containing lactate, however, has multiple side
effects and, aside from those, lactate buffers require high levels of
liver metabolism and oxygen consumption.28
In our model, as shown by others, hyperchloremia led to pro-
gressive renal vasoconstriction (increased RVR and decreased RBF)
and a fall in glomerular ﬁltration rate (decreased creatinine clear-
ance). These phenomena have been shown to be independent of
the renal nerve system and to be related to tubular chloride reab-
sorption and chloride-induced renal vasoconstriction.29 Increased
RVR and decreased creatinine clearance were most pronounced
following NaCl resuscitation and were less pronounced in the HES-
RA resuscitated group. Furthermore, HES-RA resuscitation was the
only regime that could signiﬁcantly increase renal DO2. This can
be explained by the composition of the different ﬂuids: where 0.9%
NaCl has a chloride content of 154 mmol  l−1, HES-RA has a chloride
content of 112 mmol  l−1. It should be pointed out, however, that
the improved renal oxygenation in the HES-RA group compared to
the other groups is not directly associated with acetate-balancing,
per se; rather, it is probably due to less chloride infused in HES-RA
in this MAP-targeted resuscitation protocol. Acetate itself does not
correct hyperchloremic acidosis, lactic acidosis, and does not pro-
tect renal function. However, as HES-RA resuscitation prevented
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Table 3
Renal oxygen delivery (DO2), oxygen consumption (VO2) and microvascular oxygen tension in the renal cortex (CpO2) and medulla (MpO2) at baseline (BL), during
hemorrhagic shock (HS), and after 15 and 60 min  of resuscitation (R15 and R60, respectively).
BL HS R15 R60
DO2 [ml  O2/min]
Time control 1.30 ± 0.10 1.320 ± 0.15 1.270 ± 0.08 1.40 ± 0.01
HS  control 1.420 ± 0.11 0.190 ± 0.05 0.160 ± 0.05 0.130 ± 0.05
0.9%  NaCl 1.360 ± 0.09 0.220 ± 0.01 0.330 ± 0.06 0.270 ± 0.06
Ringer’s  Acetate 1.240 ± 0.03 0.220 ± 0.04 0.480 ± 0.08H 0.410 ± 0.07H
HES-NaCl 1.390 ± 0.04 0.290 ± 0.09 0.40 ± 0.09H 0.350 ± 0.05H
HES-RA 1.320 ± 0.08 0.20 ± 0.02 0.530 ± 0.09H 0.390 ± 0.06H
VO2 [ml  O2/min/g]
Time control 0.200 ± 0.02 0.250 ± 0.01 0.240 ± 0.01 0.280 ± 0.02
HS  control 0.150 ± 0.08 0.070 ± 0.02 0.070 ± 0.02 0.060 ± 0.02
0.9%  NaCl 0.190 ± 0.06 0.070 ± 0.01 0.080 ± 0.02 0.050 ± 0.01
Ringer’s  Acetate 0.100 ± 0.03 0.060 ± 0.02 0.10 ± 0.04 0.070 ± 0.03
HES-NaCl 0.210 ±  0.03 0.110 ± 0.04 0.090 ± 0.03 0.070 ± 0.02
HES-RA  0.150 ± 0.02 0.070 ± 0.01 0.110 ± 0.03 0.110 ± 0.02
CpO2 [mmHg]
Time control 800 ± 2 780 ± 2 780 ± 2 760 ± 2
HS  control 830 ± 2 280 ± 6 220 ± 4 190 ± 5
0.9%  NaCl 850 ± 4 200 ± 2 430 ± 3 330 ± 3
Ringer’s  Acetate 750 ± 6 210 ± 3 400 ± 3 410 ± 2
HES-NaCl 810 ± 7 270 ± 4 440 ± 3 450 ± 5
HES-RA  850 ± 4 240 ± 2 530 ± 3R 500 ± 2N
MpO2 [mmHg]
Time control 670 ± 2 660 ± 1 640 ± 1 640 ± 2
HS  control 620 ± 2 190 ± 6 150 ± 2 140 ± 2
0.9%  NaCl 670 ± 3 90 ± 1 410 ± 2 300 ± 1
Ringer’s  Acetate 610 ± 4 110 ± 3 310 ± 3 300 ± 1
HES-NaCl 730 ± 1 160 ± 3 350 ± 2 300 ± 3
HES-RA 670 ±  3 220 ± 3 390 ± 6 300 ± 4
h
s
w
t
t
m
t
m
s
p
t
F
vH p < 0.05 vs. HS control.
N p < 0.05 vs. 0.9% NaCl.
R p < 0.05 vs. Ringer’s Acetate.
yperchloremic acidosis, it also led to avoiding microvascular con-
triction in renal cortex and medulla by which renal oxygenation
as improved. Therefore, in essence, this study provided evidence
hat the excess chloride in resuscitation is toxic and disturbs both
he acid–base balance and the organ function.
In this line, metabolic acidosis has been shown to be a com-
on  complication in critically ill patients and has been shown
o serve as an independent predictor of outcome.56,57 Further-
ore, restricting chloride-rich ﬂuids in intensive care has been
hown signiﬁcantly improve the acid–base status in critically ill
atients.58 However, although several animal studies, including
he present study, suggest that hyperchloremic metabolic acidosis
ig. 1. Creatinine clearance and the ratio of the renal oxygen consumption (VO2) over th
s.  time control, Np < 0.05 vs. 0.9% NaCl.leads to renal vasoconstriction and potentially to kidney dysfunc-
tion, whether this also occurs in patients remains to be veriﬁed.
The results from our study demonstrated once more the need
for larger volumes of crystalloids to achieve similar systemic
and microcirculatory goals, compared to colloids. Blood pressure
increased the ﬁrst 15–20 min  of resuscitation and then gradually
declined even though ﬂuid infusion continued. Hence, the volume
expansion effect of both crystalloids and colloids were temporary.
Nonetheless, signiﬁcantly lower volumes of colloids were required
and the colloid solutions were also more effective in maintaining
blood pressure after 1 h of resuscitation. The low efﬁcacy of the
crystalloid solutions can be explained by the fact that only 20% of
e total amount of sodium reabsorbed (TNa+ ) after 60 min  of resuscitation.
Tp < 0.05
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heir volume remains in the vascular lumen and 80% leaks out, lead-
ng to tissue edema and consequent impaired tissue oxygenation.
Excessive ﬂuid overload leads to hemodilution which even-
ually may  impair tissue oxygenation. In experimental studies
t has been demonstrated that acute isovolemic hemodilution is
ssociated with increases in red blood cell aggregation which trig-
ers endothelium-dependent thrombogenic and pro-inﬂammatory
esponses.52 Animal studies have demonstrated the direct inﬂu-
nce of hemodilution on microvascular ﬂow and renal oxygen
upply.53 Johannes et al. have found that the renal microvascular
xygenation drops at very early stages of isovolemic hemodilu-
ion. It was also shown that the kidney is particularly vulnerable to
ecreases in oxygen delivery and that the critical hematocrit asso-
iated with a decrease in microvascular oxygenation is much higher
or the kidney than for the heart or intestines.54 This was  under-
cored by a study demonstrating an increased risk of acute kidney
njury in cardiopulmonary bypass-associated hemodilution.55 The
easons for such a high sensitivity to hemodilution could involve
ndothelial dysfunction with an inﬂammatory component leading
o tissue edema and increase of diffusion distance from microcir-
ulation to the tissue cells.
Although earlier studies suggested negative effects of colloids
n microcirculation, there is increasing evidence supporting the
pposite.47 Compared to crystalloid solutions, colloid solutions
ncrease plasma viscosity. Elevating plasma viscosity in extreme
emodilution has been shown to increase microvascular ﬂow
hrough nitric oxide-mediated vasodilation.48 Others have demon-
trated the importance of sufﬁcient blood viscosity with respect
o functional capillary density and tissue oxygenation. Hence,
uring acute hemodilution as occur during aggressive ﬂuid resus-
itation, increasing plasma viscosity by administration of colloids
ay  be beneﬁcial for the microcirculation.49 Indeed, the admin-
stration of hyperoncotic and hyperviscous solutions has been
hown to be advantageous in hemorrhagic shock due to normal-
zation of colloid osmotic pressure which leads to the recovery
f microcirculatory perfusion and oxygenation.50 Furthermore,
ang et al. described that colloids improved microvascular per-
usion and reduced endothelial tissue edema. In contrast, the
uthors showed that crystalloids leak rapidly into the interstitium,
ausing endothelial tissue swelling and consequently reducing cap-
llary perfusion and increasing the oxygen diffusion distance.46
he results from the present study conﬁrm this as microvascu-
ar oxygenation in the renal cortex was lower in the crystalloid
esuscitated groups compared to the colloid resuscitated groups.
his was most marked when comparing the unbalanced crys-
alloid solution (NaCl) to the acetate-balanced colloid solution
HES-RA) and was also translated into a signiﬁcantly higher cre-
tinine clearance rate in the HES-RA group compared to the NaCl
roup.
Our study has, however, some limitations which should be
cknowledged. First, translation of the ﬁndings in our animal model
o clinical scenarios should be done with utmost care. Here, we
mitated major hemorrhage by withdrawing blood until mean arte-
ial pressure was decreased to 30 mmHg. Most trauma patients,
owever, suffer from multiple injuries which may  inﬂuence their
nﬂammatory state, potentially interfering with the hemorrhage-
nduced hypovolemia and subsequent treatment. Moreover, this
odel does not reﬂect the challenges in treatment of a neurological
rauma patient. Nonetheless, our model does demonstrate the efﬁ-
acy of volume replacement therapy using different types of ﬂuids
n renal perfusion and oxygenation after severe hemorrhage. Sec-
nd, the rather short follow-up period after of hemorrhagic shock
nd resuscitation does not allow assessment of renal (dys)function
nd injury in the long-term. Third, blood lactate and base excess
evels were not monitored in the experiments so the effects of the
ested solutions on these parameters remain to be elucidated.
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In  conclusion, while resuscitation with the NaCl and RA (crystal-
loid solutions) and the HES-NaCl (unbalanced colloid solution) led
to hyperchloremic acidosis, resuscitation with the HES-RA (acetate-
balanced colloid solution) did not. The acetate-balanced colloid
solution HES-RA was furthermore the only ﬂuid restoring renal
blood ﬂow back to ∼85% of baseline level and most prominently
improved renal microvascular oxygenation. However, the long-
term effects of HES-RA resuscitation on renal function warrants
further study.
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